Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-056461
Date:2021-09-14
Issuer: ORIC PHARMACEUTICALS, INC. (ORIC)
Original Submission Date:

Reporting Person:

HEYMAN RICHARD A.
C/O ORIC PHARMACEUTICALS, INC.
240 E. GRAND AVE., 2ND FLOOR SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-09-14 S 706 d $25.05 216,954 indirect f3
COMMON STOCK 2021-09-15 S 682 d $25.03 216,272 indirect f3
COMMON STOCK 2021-09-14 0 $0.00 12,500 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sales reported were effected pursuant to a rule 10b5-1 trading plan adopted by rahd capital, llc.
f2 represents the weighted average share price of an aggregate total of 706 shares sold in the price range of $25.00 to $25.28 by the reporting person. the reporting person undertakes to provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
f3 the shares are held of record by rahd capital, llc, and the reporting person has voting and investment power with respect to such shares.
f4 represents the weighted average share price of an aggregate total of 682 shares sold in the price range of $25.00 to $25.19 by the reporting person. the reporting person undertakes to provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Elevate your investments